Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Whats the benefit of increasing HGH
In addition to the aforementioned recently discovered evidence, KCs have been reported as promoters in AILI for releasing classical pro-inflammatory cytokines (including TNF-a, IL-1, IL-6, IL-12, IL-23) and reactive oxygen species (ROS) and reactive nitrogen species (RNS) [42, 46, 54, 55]
With that in mind, most people can begin to see results within 8 to 12 weeks or a couple of months, however, this is only the beginning part of the treatment